Krystal Biotech, Inc.
KRYS
$256.33
$6.172.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.23% | 7.20% | 10.56% | 3.23% | 1.56% |
| Total Receivables | -1.70% | 16.33% | 7.92% | -1.42% | 7.65% |
| Inventory | 7.55% | 21.23% | 3.67% | 12.95% | 42.66% |
| Prepaid Expenses | 5.84% | 61.82% | 0.78% | 26.19% | 48.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.69% | 10.02% | 9.72% | 3.34% | 4.05% |
|
|
|||||
| Total Current Assets | 10.69% | 10.02% | 9.72% | 3.34% | 4.05% |
| Net Property, Plant & Equipment | 1.09% | -1.09% | -0.56% | -1.56% | -0.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.60% | 12,596.95% | -9.63% | -5.63% | 13.79% |
| Total Assets | 7.56% | 8.93% | 5.95% | 1.76% | 7.48% |
|
|
|||||
| Total Accounts Payable | 54.41% | -70.56% | 166.62% | -46.40% | -10.66% |
| Total Accrued Expenses | 9.67% | 11.15% | 12.41% | 12.35% | 21.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.30% | 5.01% | 18.72% | 11.91% | -5.80% |
| Total Finance Division Other Current Liabilities | 24.61% | 16.37% | -28.81% | -62.43% | 9.46% |
| Total Other Current Liabilities | 24.61% | 16.37% | -28.81% | -62.43% | 9.46% |
| Total Current Liabilities | 12.79% | 5.03% | 9.32% | -22.07% | 13.93% |
|
|
|||||
| Total Current Liabilities | 12.79% | 5.03% | 9.32% | -22.07% | 13.93% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.14% | -3.11% | -2.84% | 37.33% | -2.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.71% | 12.56% | 42.70% | 37.63% | 86.47% |
| Total Liabilities | 11.76% | 4.57% | 8.92% | -18.01% | 13.46% |
|
|
|||||
| Common Stock & APIC | 2.60% | 1.56% | 1.49% | 0.18% | 1.51% |
| Retained Earnings | 188.71% | 74.45% | 26.45% | 19.78% | 20.11% |
| Treasury Stock & Other | 3.27% | -4.93% | 196.67% | 305.26% | -112.57% |
| Total Common Equity | 7.18% | 9.34% | 5.68% | 4.05% | 6.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.18% | 9.34% | 5.68% | 4.05% | 6.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.18% | 9.34% | 5.68% | 4.05% | 6.83% |
|
|
|||||